Table of Contents
Summary GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth” that provides key data, information and analysis of the major trends and issues affecting the biosimilar market in developed countries covering the US, the top five European markets and J...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Shadi
+1 (805) 652 26 26
STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important ...
... September 2012) why now Office of generic drugs (ogd)/fda has been significantly under resourced for more than a decade the pharmaceutical industry has globalized requiring fda oversight ...
Reportlinker.com © Copyright 2014. All rights reserved.